TSMHT
ELV icon

Thurston Springer Miller Herd & Titak’s Elevance Health ELV Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-360
Closed -$140K – 777
2025
Q2 		$140K Sell
360
-1
-0.3% -$402 0.02% 436
2025
Q1 		$157K Buy
361
+73
+25% +$29.3K 0.03% 369
2024
Q4 		$106K Hold
288
– – 0.02% 380
2024
Q3 		$150K Hold
288
– – 0.04% 330
2024
Q2 		$156K Buy
+288
New +$152K 0.05% 339

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's ELV Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 360 shares — an estimated $140K sold.

Thurston Springer Miller Herd & Titak first reported a position in ELV in Q2 2024 and held it in 5 quarters. The position peaked at $157K in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 360 Elevance Health shares in Q3 2025, an estimated $140K.
  • Thurston Springer Miller Herd & Titak first reported a position in Elevance Health in Q2 2024 and held it in 5 quarters.
  • Thurston Springer Miller Herd & Titak's Elevance Health position peaked at $157K in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.